Accueil - gota-technologies.com

Company

FLUIDIC TECHNOLOGY FOR OPTIMIZED SCREENING

GOTA Technologies is transforming life science research by enabling ultra-high-throughput screening and making it more precise and powerful.
With its fluorescence-activated droplet sorting (FADS) and its propietary GOTAHIT® platform, GOTA Technologies enables the testing of millions of samples in record time, opening new doors for biotechnology and synthetic biology research.

This advancement is revolutionizing how scientists identify and select biomolecules of interest, accelerating discoveries and the development of new solutions.
With GOTA Technologies, biological diversity is no longer a limitation but a field of unlimited exploration. GOTA Technologies adapts to the needs of researchers, bringing an innovative and flexible approach to pushing the boundaries of what is possible.

TECHNOLOGIES

GOTAHIT LAB-ON-A-CHIP PLATFORM

Within our L2 ambient-controlled facilities,we conduct screening services in picoliter droplets with unprecedented sensitivity and throughput. GOTAHIT can screen tens of millions of droplets per hour down to the single cell analysis.
Our expertise in the manipulation of miniaturized biological reactors spans a range of droplet-based microfluidics operations:
• Encapsulation
• Controlled incubation
• In-droplet injection
• Merging
• In-droplet transfection
• Ultra-high throughput sorting

GOTASOFT SCREENING SOFTWARE

GOTASOFT analyzes phenotypic signatures in real time with up to 8 detection channels, enabling the screening and sorting of rare events within millions of
droplets.

APPLICATIONS

We provide unique features to enable in-droplet phenotypic and functional screenings.
• antibody discovery and optimization
• cell therapy
• enzyme engineering
• bioactive secondary metabolites
(antibiotics, antifungal and anticancer)
• and much more…

We deploy our experience in custom lab-on-a-chip systems and molecular pharmacology to deliver powerful solutions to customers’ screening needs, helping them succeed in their assays

TEAM

We are a team of experts in lab-on-a-chip systems and molecular pharmacology who strongly believe in the power of droplet microfluidics screening.

Evelio R. Miquet
Chief Technology Officer

Evelio R. Miquet brings over 10 years of experience in microfluidics and lab-on-a-chip technologies for platform development.
He served as Senior Scientist in optofluidics at HiFiBiO Therapeutics (2018-2021) and as Head of the Lab-on-a-chip Unit within DEINOVE (2021-2023).
His passion for advanced technology and his entrepreneurial spirit led to the launch of GOTA Technologies.

Georges Gaudriault
Chief Executive Officer

Georges Gaudriault brings 25 years of experience in Drug Discovery, Drug Delivery and Molecular Pharmacology.
He served as CSO of MedinCell (2007-2016) and DEINOVE (2016-2022).
His vision for the potential of droplet microfluidics in the biotech and pharma industries drove the creation of GOTA Technologies.

Benoît Charlot
Chief Scientific Officer

Benoît Charlot is a research director at CNRS and head of the BioMicrofluidics and Biophotonics team at the Institut d’Electronique et des Systèmes of the University of Montpellier. For over 15 years he has developed microfluidic and organ-on-chip systems in the fields of neurosciences, oncology and hemophysics.
He has also been involved in the development of multiphase microfluidic systems for the generation of droplets and double emulsions.